Status:
COMPLETED
Safety of NGOIS Compared to BSS Plus in Pediatric Patients
Lead Sponsor:
Alcon Research
Conditions:
Cataract
Eligibility:
All Genders
1-17 years
Phase:
PHASE3
Brief Summary
To evaluate the Safety of Next Generation Ophthalmic Irrigating Solution compared to BSS Plus for use during cataract surgery in Pediatric patients.
Eligibility Criteria
Inclusion
- Cataract present.
- Other protocol-defined inclusion criteria may apply.
Exclusion
- As per age requirements.
- Other protocol-defined exclusion criteria may apply.
Key Trial Info
Start Date :
July 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2007
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT00346528
Start Date
July 1 2006
End Date
June 1 2007
Last Update
March 5 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Contact Alcon for Trial Locations
Fort Worth, Texas, United States, 76134